Triple Therapy with First Generation Protease Inhibitors for Hepatitis C Markedly Impairs Function of Neutrophil Granulocytes

First-generation HCV protease inhibitors represent a milestone in antiviral therapy for chronic hepatitis C infection (CHC), but substantially increased rates of viral clearance are offset by increased rates of infection and infection-associated deaths, especially of patients with advanced liver dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Spindelboeck, Walter, Horvath, Angela, Tawdrous, Monika, Schmerböck, Bianca, Zettel, Gabriele, Posch, Andreas, Streit, Andrea, Jurse, Petra, Lemesch, Sandra, Horn, Martin, Wuensch, Gerit, Stiegler, Philipp, Stauber, Rudolf E., Leber, Bettina, Stadlbauer, Vanessa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777445/
https://www.ncbi.nlm.nih.gov/pubmed/26938078
http://dx.doi.org/10.1371/journal.pone.0150299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777445/
https://www.ncbi.nlm.nih.gov/pubmed/26938078
http://dx.doi.org/10.1371/journal.pone.0150299

Ejemplares similares